Zafgen Announces Positive Full Results in Phase 2 Proof-of-Concept Trial of ZGN-1061 in Patients with Difficult-to-Control Type 2 Diabetes Read more about Zafgen Announces Positive Full Results in Phase 2 Proof-of-Concept Trial of ZGN-1061 in Patients with Difficult-to-Control Type 2 Diabetes Zafgen, Inc. Appoints Industry Veteran and Healthcare Policy Expert Dr. Wendy Everett to its Board of Directors Read more about Zafgen, Inc. Appoints Industry Veteran and Healthcare Policy Expert Dr. Wendy Everett to its Board of Directors Zafgen, Inc. Expands Executive Leadership Team with Appointment of Brian McVeigh as Chief Business Officer Read more about Zafgen, Inc. Expands Executive Leadership Team with Appointment of Brian McVeigh as Chief Business Officer Zafgen Reports First Quarter 2018 Operating and Financial Results Read more about Zafgen Reports First Quarter 2018 Operating and Financial Results Zafgen to Present at Deutsche Bank 43rd Annual Health Care Conference Read more about Zafgen to Present at Deutsche Bank 43rd Annual Health Care Conference Zafgen to Host Conference Call to Discuss First Quarter 2018 Financial Results Read more about Zafgen to Host Conference Call to Discuss First Quarter 2018 Financial Results Zafgen to Present at Cowen 38th Annual Health Care Conference Read more about Zafgen to Present at Cowen 38th Annual Health Care Conference Zafgen Reports Fourth Quarter and Full Year 2017 Financial Results; Announces Positive Interim Data from Ongoing ZGN-1061 Phase 2 Proof-of-Concept Trial in Patients with Type 2 Diabetes Read more about Zafgen Reports Fourth Quarter and Full Year 2017 Financial Results; Announces Positive Interim Data from Ongoing ZGN-1061 Phase 2 Proof-of-Concept Trial in Patients with Type 2 Diabetes Zafgen to Host Conference Call to Discuss Fourth Quarter and Full Year 2017 Financial Results Read more about Zafgen to Host Conference Call to Discuss Fourth Quarter and Full Year 2017 Financial Results Zafgen to Present at the Leerink Partners 7th Annual Global Healthcare Conference Read more about Zafgen to Present at the Leerink Partners 7th Annual Global Healthcare Conference Pagination First page « First Previous page ‹ Previous … Page 8 Page 9 Page 10 Page 11 Current page 12 Page 13 Page 14 Page 15 Page 16 … Next page Next › Last page Last » Subscribe to
Zafgen Announces Positive Full Results in Phase 2 Proof-of-Concept Trial of ZGN-1061 in Patients with Difficult-to-Control Type 2 Diabetes Read more about Zafgen Announces Positive Full Results in Phase 2 Proof-of-Concept Trial of ZGN-1061 in Patients with Difficult-to-Control Type 2 Diabetes
Zafgen, Inc. Appoints Industry Veteran and Healthcare Policy Expert Dr. Wendy Everett to its Board of Directors Read more about Zafgen, Inc. Appoints Industry Veteran and Healthcare Policy Expert Dr. Wendy Everett to its Board of Directors
Zafgen, Inc. Expands Executive Leadership Team with Appointment of Brian McVeigh as Chief Business Officer Read more about Zafgen, Inc. Expands Executive Leadership Team with Appointment of Brian McVeigh as Chief Business Officer
Zafgen Reports First Quarter 2018 Operating and Financial Results Read more about Zafgen Reports First Quarter 2018 Operating and Financial Results
Zafgen to Present at Deutsche Bank 43rd Annual Health Care Conference Read more about Zafgen to Present at Deutsche Bank 43rd Annual Health Care Conference
Zafgen to Host Conference Call to Discuss First Quarter 2018 Financial Results Read more about Zafgen to Host Conference Call to Discuss First Quarter 2018 Financial Results
Zafgen to Present at Cowen 38th Annual Health Care Conference Read more about Zafgen to Present at Cowen 38th Annual Health Care Conference
Zafgen Reports Fourth Quarter and Full Year 2017 Financial Results; Announces Positive Interim Data from Ongoing ZGN-1061 Phase 2 Proof-of-Concept Trial in Patients with Type 2 Diabetes Read more about Zafgen Reports Fourth Quarter and Full Year 2017 Financial Results; Announces Positive Interim Data from Ongoing ZGN-1061 Phase 2 Proof-of-Concept Trial in Patients with Type 2 Diabetes
Zafgen to Host Conference Call to Discuss Fourth Quarter and Full Year 2017 Financial Results Read more about Zafgen to Host Conference Call to Discuss Fourth Quarter and Full Year 2017 Financial Results
Zafgen to Present at the Leerink Partners 7th Annual Global Healthcare Conference Read more about Zafgen to Present at the Leerink Partners 7th Annual Global Healthcare Conference